Accretion Pharmaceuticals Ltd

Name: Accretion Pharmaceuticals Ltd Share Price Today, Stock Analysis
Brand: Accretion Pharmaceuticals Ltd

Stock Card

NSE: ACCPL

₹186.00

₹0.00 (0.00%)

As on 27-Oct-2026 09:47IST

Market cap

₹207 Cr

Revenue (TTM)

₹90 Cr

P/E Ratio

21.4

P/B Ratio

Div. Yield

0 %

Accretion Pharmaceuticals Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.00 High: 0.00

52 Week Range

Low: 0.00 High: 220.00

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹10 Cr
ROE

28.7 %
ROCE

29.8 %
Industry P/E

42.4
EV/EBITDA

14.2
Debt to Equity

0.2
Book Value

₹46.9
EPS

₹8.7
Face value

10
Shares outstanding

11,116,000

Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Accretion Pharmaceuticals	111.7	-8.5	13.3	221.5	--	--	--
BSE Healthcare	11.7	-6.0	-1.8	8.1	21.6	14.0	11.6

As on 27-Oct-2026

The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Accretion Pharmaceuticals	186.0	206.8	89.6	9.7	--	28.7	21.4	4.0
Acutaas Chemicals	3,424.3	27,409.2	1,461.8	387.4	34.5	25.2	71	15.9
Cohance Lifesciences	464.1	17,718.1	2,141.5	58.5	5.8	3.3	166.8	4.6
Granules India	843.3	22,363.9	5,632.3	662.4	17.2	14.3	33.8	4.6
Jubilant Pharmova	945.1	14,943.8	8,608.3	351.6	8.7	5.7	42.4	2.1
Natco Pharma	790.3	15,499.2	3,484.6	1,013.8	24.6	12.8	13.5	1.7
Onesource Specialty Pharma	1,424.6	16,011.9	1,543.3	-48.6	3.6	-0.6	--	2.7
Piramal Pharma	199.0	25,981.3	9,205.3	-371.8	1.7	-3.8	--	3.2
Rubicon Research	1,528.3	24,746.4	1,935.8	288.2	20.6	29.8	85.9	18.4
Wockhardt	1,850.3	29,435.5	3,564.0	414.0	15.3	8.4	72	5.8

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Accretion Pharmaceuticals

Incorporated

2023
Chairman

Harshad Nanubhai Rathod
Managing Director

Vivek Ashok Kumar Patel
Headquarters

Ahmedabad, Gujarat
Website

www.accretionpharma.com

Looking for more details about Accretion Pharmaceuticals Ltd’s IPO? Explore our IPO Details page.

FAQs for Accretion Pharmaceuticals

What is the current share price of Accretion Pharmaceuticals Ltd Today?

The share price of Accretion Pharmaceuticals Ltd is ₹186.00 (NSE) as of 27-Oct-2026 09:47 IST. Accretion Pharmaceuticals Ltd has given a return of 221.52% in the last 1 years.

What is the current PB & PE ratio of Accretion Pharmaceuticals Ltd?

The P/E ratio of Accretion Pharmaceuticals Ltd is 21.39 times as on 26-Oct-2026, a 50 discount to its peers’ median range of 42.40 times.
The P/B ratio of Accretion Pharmaceuticals Ltd is 3.97 times as on 26-Oct-2026, a 13 discount to its peers’ median range of 4.58 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2026	7.31	1.35
2025	0.00	0.00
2024	0.00	0.00
2026	7.31	1.35
2025	0.00	0.00

What is the 52 Week High and Low of Accretion Pharmaceuticals Ltd?

The 52-week high and low of Accretion Pharmaceuticals Ltd are Rs 220.00 and Rs 0.00 as of 27-Oct-2026.

What is the market cap of Accretion Pharmaceuticals Ltd?

Accretion Pharmaceuticals Ltd has a market capitalisation of ₹ 207 Cr as on 26-Oct-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Accretion Pharmaceuticals Ltd?

Before investing in Accretion Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.